Sign in

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

e-ISSN 1726-9148
p-ISSN 1726-913X
Authors GuideSubmit manuscript

Outline

https://doi.org/10.5812/ijem.5014

Mid-Trimester Maternal Serum hCG and Alpha Fetal Protein Levels: Clinical Significance and Prediction of Adverse Pregnancy Outcome

Authors

Georgios Androutsopoulos1,*, Panagiotis Gkogkos1, Georgios Decavalas1
1Department of Obstetrics and Gynaecology, University of Patras, Medical School, Rion, Greece
*Corresponding Author: Nikolaou Apostoli 21, Patra, 26332, Greece, [email protected]. Tel: +30-2613604010. Fax: +30-6974088092. Email: [email protected]
International Journal of Endocrinology and Metabolism:Vol. 11, issue 2; 102-6
Published online:Mar 31, 2013
Article type:Review Article
Received:Apr 02, 2012
Accepted:Oct 07, 2012
How to Cite:Androutsopoulos G, Gkogkos P, Decavalas G. Mid-Trimester Maternal Serum hCG and Alpha Fetal Protein Levels: Clinical Significance and Prediction of Adverse Pregnancy Outcome. Int J Endocrinol Metab. 2013;11(2):. doi: https://doi.org/10.5812/ijem.5014

Abstract

Context:

Maternal serum human Chorionic Gonadotropin (hCG) and Alpha Fetal Protein (AFP) were originally introduced to detect trisomy 21 and neural tube defects. However, in the absence of aneuploidy or neural tube defects, mid-trimester maternal serum hCG and/or maternal serum AFP associated with adverse pregnancy outcomes. Pregnancies with unexplained mid-trimester elevation in maternal serum hCG and/or maternal serum AFP, are at increased risk for pregnancy complications resulting from placental insufficiency.

Evidence Acquisition:

Mid-trimester maternal serum hCG>2.5 MoM associated with an increased risk for pregnancy complications including: late fetal loss, gestational hypertension, preeclampsia, intrauterine growth restriction (IUGR), preterm delivery and intrauterine fetal death(IUFD). Mid-trimester maternal serum AFP levels >2.5 MoM are thought to reflect a defect in placentation and associated with an increased risk for pregnancy complications including: late fetal loss, gestational hypertension, preeclampsia, IUGR, preterm delivery and IUFD.

Results:

Combined mid-trimester elevation in maternal serum hCG and AFP levels suggest a more complex type of placental pathology. They have stronger association with pregnancy complications including: late fetal loss, gestational hypertension, preeclampsia, IUGR, preterm delivery and IUFD.

Conclusions:

Mid-trimester maternal serum hCG or AFP levels alone cannot detect all pregnant women with increased risk to develop pregnancy complications. Multiparameter testing of placental function in mid-trimester (maternal serum hCG and AFP screening, uterine artery Doppler and placental morphology) may allow us to identify women with increased risk to develop severe placental insufficiency and pregnancy complications. However, future prospective studies are needed to confirm the prognostic significance of multiparameter testing of placental function in mid-trimester.

KeywordsMaternal Serum Screening TestsChorionic GonadotropinAFPAdverse Pregnancy Outcome

Full Text

Full text is available in PDF

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

27
Oct
2021
Evaluation of Second-Trimester Maternal Serum AFP Value in the Detection of Congenital Heart Defects

Evaluation of Second-Trimester Maternal Serum AFP Value in the Detection of Congenital Heart Defects

Shahrzad Aghaamoo,
Maryam Lotfi,
Majid Mirmohammadkhani,
Mohammad Nasir Hemmatian
PDF

Aghaamoo S, Lotfi M, Mirmohammadkhani M, Hemmatian MN. Evaluation of Second-Trimester Maternal Serum AFP Value in the Detection of Congenital Heart Defects. Middle East J Rehabil Health Stud. 2021;8(4):e111917. doi: https://doi.org/10.5812/mejrh.111917

18
Apr
2022

Placental Size and Uterine Artery Doppler for Prediction of Adverse Pregnancy Outcomes in Women with Low Pregnancy-Associated Plasma Protein-A

Ashraf Jamal,
Shohreh Vosoogh,
Razieh Sadat Tabatabaei,
Fatemeh Salamat
PDF

Jamal A, Vosoogh S, Tabatabaei RS, Salamat F. Placental Size and Uterine Artery Doppler for Prediction of Adverse Pregnancy Outcomes in Women with Low Pregnancy-Associated Plasma Protein-A. Shiraz E-Med J. 2022;23(7):e120716. doi: https://doi.org/10.5812/semj-120716

6
May
2025
Serum Magnesium and Nitric Oxide Levels in Early Detection of Pre-eclampsia and Gestational Hypertension

Serum Magnesium and Nitric Oxide Levels in Early Detection of Pre-eclampsia and Gestational Hypertension

Jenu Maria Thomas,
Revathi P Shenoy,
Parvati V Bhat,
Asha Kamath,
Krishnananda Prabhu,
Shashikiran Umakanth
PDF

Maria Thomas J, P Shenoy R, V Bhat P, Kamath A, Prabhu K, et al. Serum Magnesium and Nitric Oxide Levels in Early Detection of Pre-eclampsia and Gestational Hypertension. Fertil Gynecol Androl. 2025;5(1):e154402. doi: https://doi.org/10.5812/fga-154402

30
Sep
2017

Predictive Power of Human Chorionic Gonadotropin in Post-Molar Gestational Trophoblastic Neoplasia: A Longitudinal Roc Analysis

Azin Khosravirad,
Farid Zayeri,
Ahmad Reza Baghestani,
Moein Yoosefi,
Mahmood Bakhtiyari
PDF

Khosravirad A, Zayeri F, Baghestani AR, Yoosefi M, Bakhtiyari M. Predictive Power of Human Chorionic Gonadotropin in Post-Molar Gestational Trophoblastic Neoplasia: A Longitudinal Roc Analysis. Int J Cancer Manag. 2017;10(9):e9015. doi: https://doi.org/10.5812/ijcm.9015

31
Mar
2023

The Relationship Between the Full Biophysical Profile and Rapid Biophysical Profile in Antepartum Fetal Surveillance

Hamideh Pakniat,
Ezzatalsadat Hajiseid Javadi,
Venus Chegini,
Nahid Khajevand,
Simindokht Molaverdikhani
PDF

Pakniat H, Hajiseid Javadi E, Chegini V, Khajevand N, Molaverdikhani S. The Relationship Between the Full Biophysical Profile and Rapid Biophysical Profile in Antepartum Fetal Surveillance. J Inflamm Dis. 2024;26(4):e156326. doi:

More by these authors

Georgios AndroutsopoulosPubMedScholar
Panagiotis GkogkosPubMedScholar
Georgios DecavalasPubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF615.27 KB
Import into EndNoteImport into BibTex
Share
Cited by
Metrics
Comments
Number of Comments:0